Cargando…

Extracellular volume quantification by dynamic equilibrium cardiac computed tomography in cardiac amyloidosis

BACKGROUND: Cardiac involvement determines outcome in patients with systemic amyloidosis. There is major unmet need for quantification of cardiac amyloid burden, which is currently only met in part through semi-quantitative bone scintigraphy or Cardiovascular Magnetic Resonance (CMR), which measures...

Descripción completa

Detalles Bibliográficos
Autores principales:	Treibel, Thomas A., Bandula, Steve, Fontana, Marianna, White, Steven K., Gilbertson, Janet A., Herrey, Anna S., Gillmore, Julian D., Punwani, Shonit, Hawkins, Philip N., Taylor, Stuart A., Moon, James C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4684159/ https://www.ncbi.nlm.nih.gov/pubmed/26209459 http://dx.doi.org/10.1016/j.jcct.2015.07.001

Ejemplares similares

Native T1 mapping in ATTR cardiac amyloidosis - comparison with AL cardiac amyloidosis - a 200 patient study
por: Fontana, Marianna, et al.
Publicado: (2014)

Transthyretin cardiac amyloidosis
por: Porcari, Aldostefano, et al.
Publicado: (2022)

Diflunisal therapy for cardiac ATTR amyloidosis: a longitudinal, prospective, single centre study
por: Quarta, Candida C, et al.
Publicado: (2015)

Multiorgan ECV as measured by EQ-MRI in systemic amyloidosis
por: Banypersad, Sanjay M, et al.
Publicado: (2013)

Imaging-Guided Treatment for Cardiac Amyloidosis
por: Ioannou, Adam, et al.
Publicado: (2022)

Disease progression in cardiac transthyretin amyloidosis is indicated by serial calculation of National Amyloidosis Centre transthyretin amyloidosis stage
por: Law, Steven, et al.
Publicado: (2020)

Diagnostic sensitivity of abdominal fat aspiration in cardiac amyloidosis
por: Quarta, Candida Cristina, et al.
Publicado: (2017)

Cardiac Amyloidosis: A Review of Current Imaging Techniques
por: Razvi, Yousuf, et al.
Publicado: (2021)

Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis
por: Fontana, Marianna, et al.
Publicado: (2015)

Cardiac biomarkers are prognostic in systemic light chain amyloidosis with no cardiac involvement by standard criteria
por: Sharpley, Faye A., et al.
Publicado: (2020)

Characteristics and natural history of early-stage cardiac transthyretin amyloidosis
por: Law, Steven, et al.
Publicado: (2022)

Spotting senile systemic amyloidosis: why we miss it
por: Fontana, Marianna, et al.
Publicado: (2015)

Prevalence of Cardiac Amyloidosis in Patients Referred for Transcatheter Aortic Valve Replacement
por: Scully, Paul R., et al.
Publicado: (2018)

LGE-PSIR is an independent predictor of mortality in cardiac amyloidosis: a 250 patient prospective study
por: Fontana, Marianna, et al.
Publicado: (2015)

DPD Quantification in Cardiac Amyloidosis: A Novel Imaging Biomarker
por: Scully, Paul R., et al.
Publicado: (2020)

Clinical Importance of Left Atrial Infiltration in Cardiac Transthyretin Amyloidosis
por: Bandera, Francesco, et al.
Publicado: (2022)

Rare Forms of Cardiac Amyloidosis: Diagnostic Clues and Phenotype in Apo AI and AIV Amyloidosis
por: Ioannou, Adam, et al.
Publicado: (2023)

Cardiac involvement in cardiac AL amyloidosis as measured by equilibrium contrast cardiovascular magnetic resonance
por: Banypersad, Sanjay M, et al.
Publicado: (2012)

Tracking Multiorgan Treatment Response in Systemic AL-Amyloidosis With Cardiac Magnetic Resonance Derived Extracellular Volume Mapping
por: Ioannou, Adam, et al.
Publicado: (2023)

Progression of echocardiographic parameters and prognosis in transthyretin cardiac amyloidosis
por: Chacko, Liza, et al.
Publicado: (2022)

Cardiac Amyloidosis: Updates in Imaging
por: Chacko, Liza, et al.
Publicado: (2019)

Equilibrium CT Texture Analysis for the Evaluation of Hepatic Fibrosis: Preliminary Evaluation against Histopathology and Extracellular Volume Fraction
por: Yeung, Jason, et al.
Publicado: (2020)

AL and ATTR cardiac amyloid are different: native T1 mapping and ECV detect different biology
por: Fontana , Marianna, et al.
Publicado: (2014)

Prevalence and Outcomes of Concomitant Aortic Stenosis and Cardiac Amyloidosis
por: Nitsche, Christian, et al.
Publicado: (2021)

Novel quantification of extracellular expansion by cardiac magnetic resonance is a robust marker in diagnosis of cardiac amyloidosis
por: Mongeon, Francois-Pierre, et al.
Publicado: (2011)

Long-term biopsy outcomes in prostate cancer patients treated with external beam radiotherapy: a systematic review and meta-analysis
por: Singh, Saurabh, et al.
Publicado: (2021)

Cardiac amyloid burden assessment by T1 mapping predicts survival in patients with systemic AL amyloidosis - a 2 year follow-up study
por: Banypersad, Sanjay M, et al.
Publicado: (2014)

Atrial Involvement in Cardiac Amyloidosis: Beyond Dilatation
por: Fontana, Marianna, et al.
Publicado: (2020)

Empirical use of anakinra in AA amyloidosis of uncertain aetiology
por: Lane, T, et al.
Publicado: (2015)

(99m)Tc-DPD scintigraphy in immunoglobulin light chain (AL) cardiac amyloidosis
por: Quarta, Candida Cristina, et al.
Publicado: (2021)

Diagnostic value of fat aspirates for amyloidosis in 950 patients
por: Gilbertson, JA, et al.
Publicado: (2015)

RNA Targeting and Gene Editing Strategies for Transthyretin Amyloidosis
por: Ioannou, Adam, et al.
Publicado: (2023)

Extracellular volume quantification in isolated hypertension - changes at the detectable limits?
por: Treibel, Thomas A., et al.
Publicado: (2015)

Tc-99m labelled bone scintigraphy in suspected cardiac amyloidosis
por: Rauf, Muhammad Umaid, et al.
Publicado: (2023)

Occult senile cardiac amyloid in severe calcific aortic stenosis is not rare and has a poor prognosis: a 146 patient CMR biopsy study
por: Treibel, Thomas A, et al.
Publicado: (2016)

3.0T cardiac magnetic resonance quantification of native T1 and myocardial extracellular volume for the diagnosis of late gadolinium enhancement-negative cardiac amyloidosis
por: Liu, Yumeng, et al.
Publicado: (2022)

Conventional heart failure therapy in cardiac ATTR amyloidosis
por: Ioannou, Adam, et al.
Publicado: (2023)

T1 mapping and survival in systemic light-chain amyloidosis
por: Banypersad, Sanjay M., et al.
Publicado: (2015)

Quality of life in ATTR amyloidosis
por: Lane, Thirusha, et al.
Publicado: (2015)

British Society of Echocardiography guideline for the transthoracic echocardiographic assessment of cardiac amyloidosis
por: Moody, William E., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_r41shtdpkt574cj6207ainu6bh